Our findings highlight Itgb1 as a potential therapeutic target for PCOS and propose that clinical treatment should utilize low-frequency EA at primary acupoints, supplemented with additional acupoints based on disease phenotype, combined with MA for enhanced efficacy. The gene discussed is ITGB1; the disease is polycystic ovary syndrome.